Publications
Sort & Filters
Filters
48 results
48 results
2025
Shirole NH, Kesar D, Lee Y, Goodale A, Syamala S, Kukreja S, Li R, Qiu X, Yu W, Goldman S, Cejas P, Long HW, Adelman K, Doench JG, Sellers WR, Kaelin WG Jr. Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer.
Cancer Discovery. 2025;15:1484–1504.
Shirole NH, Kesar D, Lee Y, Goodale A, Syamala S, Kukreja S, Li R, Qiu X, Yu W, Goldman S, Cejas P, Long HW, Adelman K, Doench JG, Sellers WR, Kaelin WG Jr. Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer.
Cancer Discovery. 2025;15:1484–1504.
We discovered that cyclin D1 is the key target of HIF2 driving the cell-autonomous proliferation of VHL-mutant kidney cancers and that cyclin D1 has targets beyond pRB in this setting. These findings have implications for treating kidney cancer with HIF2...
Narducci DN, Hansen AS. Putative looping factor ZNF143/ZFP143 is an essential transcriptional regulator with no looping function.
Molecular Cell. 2025;85:9–23.e9.
Narducci DN, Hansen AS. Putative looping factor ZNF143/ZFP143 is an essential transcriptional regulator with no looping function.
Molecular Cell. 2025;85:9–23.e9.
Jiang Q, Braun DA, Clauser KR, Ramesh V, Shirole NH, Duke-Cohan JE, Nabilsi N, Kramer NJ, Forman C, Lippincott IE, Klaeger S, Phulphagar KM, Chea V, Kim N, Vanasse AP, Saad E, Parsons T, Carr-Reynolds M, Carulli I, Pinjusic K, Jiang Y, Li R, Syamala S, Rachimi S, Verzani EK, Stevens JD, Lane WJ, Camp SY, Meli K, Pappalardi MB, Herbert ZT, Qiu X, Cejas P, Long HW, Shukla SA, Van Allen EM, Choueiri TK, Churchman S, Abelin JG, Gurer C, MacBeath G, Childs RW, Carr SA, Keskin DB, Wu CJ, Kaelin WG. HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy.
Cell. 2025;
Jiang Q, Braun DA, Clauser KR, Ramesh V, Shirole NH, Duke-Cohan JE, Nabilsi N, Kramer NJ, Forman C, Lippincott IE, Klaeger S, Phulphagar KM, Chea V, Kim N, Vanasse AP, Saad E, Parsons T, Carr-Reynolds M, Carulli I, Pinjusic K, Jiang Y, Li R, Syamala S, Rachimi S, Verzani EK, Stevens JD, Lane WJ, Camp SY, Meli K, Pappalardi MB, Herbert ZT, Qiu X, Cejas P, Long HW, Shukla SA, Van Allen EM, Choueiri TK, Churchman S, Abelin JG, Gurer C, MacBeath G, Childs RW, Carr SA, Keskin DB, Wu CJ, Kaelin WG. HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy.
Cell. 2025;
Baluapuri A, Zhao NC, Marina RJ, Huang KL, Kuzkina A, Amodeo ME, Stein CB, Ahn LY, Farr JS, Schaffer AE, Khurana V, Wagner EJ, Adelman K. Integrator loss leads to dsRNA formation that triggers the integrated stress response.
Cell. 2025;
Baluapuri A, Zhao NC, Marina RJ, Huang KL, Kuzkina A, Amodeo ME, Stein CB, Ahn LY, Farr JS, Schaffer AE, Khurana V, Wagner EJ, Adelman K. Integrator loss leads to dsRNA formation that triggers the integrated stress response.
Cell. 2025;
Integrator (INT) is a metazoan-specific complex that targets promoter-proximally paused RNA polymerase II (RNAPII) for termination, preventing immature RNAPII from entering gene bodies and functionally attenuating transcription of stress-responsive genes...
Kim G, Carroll CL, Wakefield ZP, Tuncay M, Fiszbein A. U1 snRNP regulates alternative promoter activity by inhibiting premature polyadenylation.
Molecular Cell. 2025;85:1968–1981.e7.
Kim G, Carroll CL, Wakefield ZP, Tuncay M, Fiszbein A. U1 snRNP regulates alternative promoter activity by inhibiting premature polyadenylation.
Molecular Cell. 2025;85:1968–1981.e7.
Wang Y, Baluapuri A, Manokaran C, Ni J, Jiang T, Janssens RC, Marteijn JA, Adelman K, Zhao J, Roberts TM. Dual Modes of Gene Regulation by CDK12.
bioRxiv; 2025.
Wang Y, Baluapuri A, Manokaran C, Ni J, Jiang T, Janssens RC, Marteijn JA, Adelman K, Zhao J, Roberts TM. Dual Modes of Gene Regulation by CDK12.
bioRxiv; 2025.
The process of transcription is driven forward by the activity of kinases including CDK7, CDK9 and CDK12. Accordingly, acute inhibition of any of these kinases results in profound downregulation of gene expression. Here, we discover that loss or...
Zhang S, Engel K, Fahs A, Malone CF, Ross K, Just M, Guedes B, Granum D, Oristian KM, Kovach A, Alexe G, Digiovanni G, Barbar L, Bentley R, Cerda-Smith C, Le Roux O, Mendes E, Zimmerman SP, Rees M, Roth J, Shern JF, Wood KC, Counter CM, Linardic CM, Stegmaier K. CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.
bioRxiv; 2025.
Zhang S, Engel K, Fahs A, Malone CF, Ross K, Just M, Guedes B, Granum D, Oristian KM, Kovach A, Alexe G, Digiovanni G, Barbar L, Bentley R, Cerda-Smith C, Le Roux O, Mendes E, Zimmerman SP, Rees M, Roth J, Shern JF, Wood KC, Counter CM, Linardic CM, Stegmaier K. CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.
bioRxiv; 2025.
Alveolar rhabdomyosarcoma (aRMS) is a fusion-driven pediatric cancer with poor survival and limited therapeutic options. To uncover novel vulnerabilities, we employed complex-based analysis of the DepMap functional genomic data, identifying CDK8 as a...
Pulice JL, Meyerson M. Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma.
Molecular Cell. 2025;85:1311–1329.e16.
Pulice JL, Meyerson M. Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma.
Molecular Cell. 2025;85:1311–1329.e16.
Martin-Rufino JD, Caulier A, Lee S, Castano N, King E, Joubran S, Jones M, Goldman SR, Arora UP, Wahlster L, Lander ES, Sankaran VG. Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes.
Science. 2025;388:52–59.
Martin-Rufino JD, Caulier A, Lee S, Castano N, King E, Joubran S, Jones M, Goldman SR, Arora UP, Wahlster L, Lander ES, Sankaran VG. Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes.
Science. 2025;388:52–59.
Most phenotype-associated genetic variants map to noncoding regulatory regions of the human genome, but their mechanisms remain elusive in most cases. We developed a highly efficient strategy, Perturb-multiome, to simultaneously profile chromatin...
2024
Kaye EG, Basavaraju K, Nelson GM, Zomer HD, Roy D, Joseph II, Rajabi-Toustani R, Qiao H, Adelman K, Reddi PP. RNA polymerase II pausing is essential during spermatogenesis for appropriate gene expression and completion of meiosis.
Nature Communications. 2024;15:848.
Kaye EG, Basavaraju K, Nelson GM, Zomer HD, Roy D, Joseph II, Rajabi-Toustani R, Qiao H, Adelman K, Reddi PP. RNA polymerase II pausing is essential during spermatogenesis for appropriate gene expression and completion of meiosis.
Nature Communications. 2024;15:848.
Male germ cell development requires precise regulation of gene activity in a cell-type and stage-specific manner, with perturbations in gene expression during spermatogenesis associated with infertility. Here, we use steady-state, nascent and single-cell...
Mehta S, Buyanbat A, Kai Y, Orkin SH. Mechanistic and kinetic insights into transcription factor biology via acute protein depletion.
Experimental Hematology. 2024;137:104250.
Mehta S, Buyanbat A, Kai Y, Orkin SH. Mechanistic and kinetic insights into transcription factor biology via acute protein depletion.
Experimental Hematology. 2024;137:104250.
Genetic downregulation of the BCL11A transcription factor (TF) reverses the switch from fetal to adult hemoglobin and is effective in treating β-hemoglobinopathies. Genetic ablation results in a gradual reduction in protein abundance and does not lend...
Heikamp EB, Martucci C, Henrich JA, Neel DS, Mahendra-Rajah S, Rice H, Wenge DV, Perner F, Wen Y, Hatton C, Armstrong SA. NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML.
Cell Reports. 2024;43.
Heikamp EB, Martucci C, Henrich JA, Neel DS, Mahendra-Rajah S, Rice H, Wenge DV, Perner F, Wen Y, Hatton C, Armstrong SA. NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML.
Cell Reports. 2024;43.